Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy
- 11 November 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 30 (3) , 334-347
Abstract
Existing therapeutic efficacy of chemotherapy and photodynamic therapy (PDT) always affected by some resistance factors from tumor environment (TME), such as hypoxia and antioxidant defense system....Keywords
This publication has 50 references indexed in Scilit:
- Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesisNature Communications, 2016
- Potent Antimalarial Activity of Acriflavine In Vitro and In VivoACS Chemical Biology, 2014
- Modulation of oxidative stress as an anticancer strategyNature Reviews Drug Discovery, 2013
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasisJournal of Molecular Medicine, 2012
- Novel activity of acriflavine against colorectal cancer tumor cellsCancer Science, 2011
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathwaysDrug Resistance Updates, 2011
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationProceedings of the National Academy of Sciences, 2009
- Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposomeJournal of Controlled Release, 2006